@article{ElHelouBiegnerBodeetal.2019,
  author    = {El-Helou, Sabine M. and Biegner, Anika-Kerstin and Bode, Sebastian and Ehl, Stephan R. and Heeg, Maximilian and Maccari, Maria E. and Ritterbusch, Henrike and Speckmann, Carsten and Rusch, Stephan and Scheible, Raphael and Warnatz, Klaus and Atschekzei, Faranaz and Beider, Renata and Ernst, Diana and Gerschmann, Stev and Jablonka, Alexandra and Mielke, Gudrun and Schmidt, Reinhold E. and Sch{\"u}rmann, Gesine and Sogkas, Georgios and Baumann, Ulrich H. and Klemann, Christian and Viemann, Dorothee and Bernuth, Horst von and Kr{\"u}ger, Renate and Hanitsch, Leif G. and Scheibenbogen, Carmen M. and Wittke, Kirsten and Albert, Michael H. and Eichinger, Anna and Hauck, Fabian and Klein, Christoph and Rack-Hoch, Anita and Sollinger, Franz M. and Avila, Anne and Borte, Michael and Borte, Stephan and Fasshauer, Maria and Hauenherm, Anja and Kellner, Nils and M{\"u}ller, Anna H. and {\"U}lzen, Anett and Bader, Peter and Bakhtiar, Shahrzad and Lee, Jae-Yun and Heß, Ursula and Schubert, Ralf and W{\"o}lke, Sandra and Zielen, Stefan and Ghosh, Sujal and Laws, Hans-Juergen and Neubert, Jennifer and Oommen, Prasad T. and H{\"o}nig, Manfred and Schulz, Ansgar and Steinmann, Sandra and Klaus, Schwarz and D{\"u}ckers, Gregor and Lamers, Beate and Langemeyer, Vanessa and Niehues, Tim and Shai, Sonu and Graf, Dagmar and M{\"u}glich, Carmen and Schmalzing, Marc T. and Schwaneck, Eva C. and Tony, Hans-Peter and Dirks, Johannes and Haase, Gabriele and Liese, Johannes G. and Morbach, Henner and Foell, Dirk and Hellige, Antje and Wittkowski, Helmut and Masjosthusmann, Katja and Mohr, Michael and Geberzahn, Linda and Hedrich, Christian M. and M{\"u}ller, Christiane and R{\"o}sen-Wolff, Angela and Roesler, Joachim and Zimmermann, Antje and Behrends, Uta and Rieber, Nikolaus and Schauer, Uwe and Handgretinger, Rupert and Holzer, Ursula and Henes, J{\"o}rg and Kanz, Lothar and Boesecke, Christoph and Rockstroh, J{\"u}rgen K. and Schwarze-Zander, Carolynne and Wasmuth, Jan-Christian and Dilloo, Dagmar and H{\"u}lsmann, Brigitte and Sch{\"o}nberger, Stefan and Schreiber, Stefan and Zeuner, Rainald and Ankermann, Tobias and Bismarck, Philipp von and Huppertz, Hans-Iko and Kaiser-Labusch, Petra and Greil, Johann and Jakoby, Donate and Kulozik, Andreas E. and Metzler, Markus and Naumann-Bartsch, Nora and Sobik, Bettina and Graf, Norbert and Heine, Sabine and Kobbe, Robin and Lehmberg, Kai and M{\"u}ller, Ingo and Herrmann, Friedrich and Horneff, Gerd and Klein, Ariane and Peitz, Joachim and Schmidt, Nadine and Bielack, Stefan and Groß-Wieltsch, Ute and Classen, Carl F. and Klasen, Jessica and Deutz, Peter and Kamitz, Dirk and Lassy, Lisa and Tenbrock, Klaus and Wagner, Norbert and Bernbeck, Benedikt and Brummel, Bastian and Lara-Villacanas, Eusebia and M{\"u}nstermann, Esther and Schneider, Dominik T. and Tietsch, Nadine and Westkemper, Marco and Weiß, Michael and Kramm, Christof and K{\"u}hnle, Ingrid and Kullmann, Silke and Girschick, Hermann and Specker, Christof and Vinnemeier-Laubenthal, Elisabeth and Haenicke, Henriette and Schulz, Claudia and Schweigerer, Lothar and M{\"u}ller, Thomas G. and Stiefel, Martina and Belohradsky, Bernd H. and Soetedjo, Veronika and Kindle, Gerhard and Grimbacher, Bodo},
  title     = {The German national registry of primary immunodeficiencies (2012-2017)},
  series = {Frontiers in Immunology},
  volume    = {10},
  journal   = {Frontiers in Immunology},
  doi       = {10.3389/fimmu.2019.01272},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-226629},
  year      = {2019},
  abstract  = {Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs. Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel. Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1-25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57\% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36\% of patients. Familial cases were observed in 21\% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0-88 years). Presenting symptoms comprised infections (74\%) and immune dysregulation (22\%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE-syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49\% of all patients received immunoglobulin G (IgG) substitution (70\%-subcutaneous; 29\%-intravenous; 1\%-unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy. Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment.},
  language  = {en}
}
@article{BassetCizekCuenoudetal.2015,
  author    = {Basset, Yves and Cizek, Lukas and Cu{\´e}noud, Philippe and Didham, Raphael K. and Novotny, Vojtech and {\O}degaard, Frode and Roslin, Tomas and Tishechkin, Alexey K. and Schmidl, J{\"u}rgen and Winchester, Neville N. and Roubik, David W. and Aberlenc, Henri-Pierre and Bail, Johannes and Barrios, Hector and Bridle, Jonathan R. and Casta{\~n}o-Meneses, Gabriela and Corbara, Bruno and Curletti, Gianfranco and da Rocha, Wesley Duarte and De Bakker, Domir and Delabie, Jacques H. C. and Dejean, Alain and Fagan, Laura L. and Floren, Andreas and Kitching, Roger L. and Medianero, Enrique and de Oliveira, Evandro Gama and Orivel, Jerome and Pollet, Marc and Rapp, Mathieu and Ribeiro, Servio P. and Roisin, Yves and Schmidt, Jesper B. and S{\o}rensen, Line and Lewinsohn, Thomas M. and Leponce, Maurice},
  title     = {Arthropod Distribution in a Tropical Rainforest: Tackling a Four Dimensional Puzzle},
  series = {PLoS ONE},
  volume    = {10},
  journal   = {PLoS ONE},
  number    = {12},
  doi       = {10.1371/journal.pone.0144110},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-136393},
  pages     = {e0144110},
  year      = {2015},
  abstract  = {Quantifying the spatio-temporal distribution of arthropods in tropical rainforests represents a first step towards scrutinizing the global distribution of biodiversity on Earth. To date most studies have focused on narrow taxonomic groups or lack a design that allows partitioning of the components of diversity. Here, we consider an exceptionally large dataset (113,952 individuals representing 5,858 species), obtained from the San Lorenzo forest in Panama, where the phylogenetic breadth of arthropod taxa was surveyed using 14 protocols targeting the soil, litter, understory, lower and upper canopy habitats, replicated across seasons in 2003 and 2004. This dataset is used to explore the relative influence of horizontal, vertical and seasonal drivers of arthropod distribution in this forest. We considered arthropod abundance, observed and estimated species richness, additive decomposition of species richness, multiplicative partitioning of species diversity, variation in species composition, species turnover and guild structure as components of diversity. At the scale of our study (2km of distance, 40m in height and 400 days), the effects related to the vertical and seasonal dimensions were most important. Most adult arthropods were collected from the soil/litter or the upper canopy and species richness was highest in the canopy. We compared the distribution of arthropods and trees within our study system. Effects related to the seasonal dimension were stronger for arthropods than for trees. We conclude that: (1) models of beta diversity developed for tropical trees are unlikely to be applicable to tropical arthropods; (2) it is imperative that estimates of global biodiversity derived from mass collecting of arthropods in tropical rainforests embrace the strong vertical and seasonal partitioning observed here; and (3) given the high species turnover observed between seasons, global climate change may have severe consequences for rainforest arthropods.},
  language  = {en}
}
@article{MarenholzEsparzaGordilloRueschendorfetal.2015,
  author    = {Marenholz, Ingo and Esparza-Gordillo, Jorge and R{\"u}schendorf, Franz and Bauerfeind, Anja and Strachan, David P. and Spycher, Ben D. and Baurecht, Hansj{\"o}rg and Magaritte-Jeannin, Patricia and S{\"a}{\"a}f, Annika and Kerkhof, Marjan and Ege, Markus and Baltic, Svetlana and Matheson, Melanie C. and Li, Jin and Michel, Sven and Ang, Wei Q. and McArdle, Wendy and Arnold, Andreas and Homuth, Georg and Demenais, Florence and Bouzigon, Emmanuelle and S{\"o}derh{\"a}ll, Cilla and Pershagen, G{\"o}ran and de Jongste, Johan C. and Postma, Dirkje S. and Braun-Fahrl{\"a}nder, Charlotte and Horak, Elisabeth and Ogorodova, Ludmila M. and Puzyrev, Valery P. and Bragina, Elena Yu and Hudson, Thomas J. and Morin, Charles and Duffy, David L. and Marks, Guy B. and Robertson, Colin F. and Montgomery, Grant W. and Musk, Bill and Thompson, Philip J. and Martin, Nicholas G. and James, Alan and Sleiman, Patrick and Toskala, Elina and Rodriguez, Elke and F{\"o}lster-Holst, Regina and Franke, Andre and Lieb, Wolfgang and Gieger, Christian and Heinzmann, Andrea and Rietschel, Ernst and Keil, Thomas and Cichon, Sven and N{\"o}then, Markus M. and Pennel, Craig E. and Sly, Peter D. and Schmidt, Carsten O. and Matanovic, Anja and Schneider, Valentin and Heinig, Matthias and H{\"u}bner, Norbert and Holt, Patrick G. and Lau, Susanne and Kabesch, Michael and Weidinger, Stefan and Hakonarson, Hakon and Ferreira, Manuel A. R. and Laprise, Catherine and Freidin, Maxim B. and Genuneit, Jon and Koppelman, Gerard H. and Mel{\´e}n, Erik and Dizier, Marie-H{\´e}l{\`e}ne and Henderson, A. John and Lee, Young Ae},
  title     = {Meta-analysis identifies seven susceptibility loci involved in the atopic march},
  series = {Nature Communications},
  volume    = {6},
  journal   = {Nature Communications},
  number    = {8804},
  doi       = {10.1038/ncomms9804},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-139835},
  year      = {2015},
  abstract  = {Eczema often precedes the development of asthma in a disease course called the 'atopic march'. To unravel the genes underlying this characteristic pattern of allergic disease, we conduct a multi-stage genome-wide association study on infantile eczema followed by childhood asthma in 12 populations including 2,428 cases and 17,034 controls. Here we report two novel loci specific for the combined eczema plus asthma phenotype, which are associated with allergic disease for the first time; rs9357733 located in EFHC1 on chromosome 6p12.3 (OR 1.27; P = 2.1 x 10(-8)) and rs993226 between TMTC2 and SLC6A15 on chromosome 12q21.3 (OR 1.58; P = 5.3 x 10(-9)). Additional susceptibility loci identified at genome-wide significance are FLG (1q21.3), IL4/KIF3A (5q31.1), AP5B1/OVOL1 (11q13.1), C11orf30/LRRC32 (11q13.5) and IKZF3 (17q21). We show that predominantly eczema loci increase the risk for the atopic march. Our findings suggest that eczema may play an important role in the development of asthma after eczema.},
  language  = {en}
}
@phdthesis{Schmidt2003,
  author    = {Schmidt, Andreas H.},
  title     = {Antigenexpression von Entz{\"u}ndungszellen bei Polyposis-nasi-Patienten},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-6024},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2003},
  abstract  = {Die {\"A}tiologie und Pathogenese der Polyposis nasi ist trotz intensiver Forschung bis heute in vielen Z{\"u}gen ungekl{\"a}rt. Deshalb wurde eine histologische und immunhistochemische Arbeit bez{\"u}glich Pathomorphologie sowie Vorkommen, H{\"a}ufigkeit und Verteilung von immunkompetenten Zellen bei Nasenpolypen mit besonderer Ber{\"u}cksichtigung verschiedener histologischer Subtypen durchgef{\"u}hrt. Dazu wurden Proben von 20 Patienten intraoperativ gewonnen und nach Anfertigung von Gefrierschnitten histologisch mit H{\"a}malaun- Eosin und immunhistochemisch mit 8 spezifischen Antik{\"o}rpern gef{\"a}rbt. Die lichtmikroskopische Auswertung erfolgte qualitativ durch histologische Subtypisierung in Anlehnung an KAKOI und HIRAIDE (1987) in {\"o}demat{\"o}se, glandul{\"a}r- zystische und fibr{\"o}se Polypen und indem Epithel, Basalmembran (HE), Aktivierungszustand (ICAM- 1) und Gef{\"a}ßverteilung (Collagen IV) beurteilt wurden. Es folgte eine semiquantitative Analyse des eosinophilen Infiltrates (HE), der Lymphozyten mit Schwerpunkt auf T- Zellen (LFA- 1, CD4, CD8) und der antigenpr{\"a}sentierenden Zellen (HLA- DR, CD14, CD1). Die Ergebnisse zeigten {\"u}berall mehrschichtiges Flimmerepithel ohne Metaplasien und zahlreiche Gef{\"a}ße, die subepithelial mehr rund, im Stroma mehr sinusoid waren. Die Basalmembran war d{\"u}nn bis stark verdickt. Die basale Epithelschicht war durchweg aktiviert, ebenso wie periglandul{\"a}re Zellen beim glandul{\"a}r- zystischen Typ. Eosinophile Granulozyten fanden sich lediglich beim {\"o}demat{\"o}sen Typ regelm{\"a}ßig. Lymphozyten waren zahlenm{\"a}ßig den Eosinophilen {\"u}berlegen und es zeigte sich ein {\"U}berwiegen der CD8+- Zellen beim glandul{\"a}r- zystischen und der CD4+- Zellen beim {\"o}demat{\"o}sen und fibr{\"o}sen Typ. Die Expression von CD1 fand sich lediglich beim glandul{\"a}r- zystischen Typ, w{\"a}hrend die beiden anderen CD14- und HLA-DR- Expression zeigten. Es wird die Hypothese aufgestellt, daß es sich bei den Subtypen der Polyposis nasi nicht um vernachl{\"a}ssigbare histologische Varianten, sondern um Stadien der Pathogenese handelt, m{\"o}glicherweise vom glandul{\"a}r- zystischen, mit initialem, periglandul{\"a}rem T8- Killerzellinfiltrat, {\"u}ber den {\"o}demat{\"o}sen, mit eosinophilem Infiltrat und der Entwicklung einer sekund{\"a}ren, APC- vermittelten und auf einer bakteriell/ mykotischen Besiedelung beruhenden T4- Helferzellinfiltration, zum fibr{\"o}sen Polypen mit Kumulieren der entz{\"u}ndlichen Infiltration und finaler Fibroblasteneinwanderung und Fibrosierung.},
  language  = {de}
}